Nikola Misljencevic
Director Business Development & Transactions AbCellera
Nik Misljencevic is Director of Business Development & Transactions at AbCellera, where he focuses on strategic partnerships, deal execution, and collaborations supporting the company’s antibody discovery platform. He brings a combination of business development expertise and scientific research experience, enabling him to bridge technical innovation with commercial strategy in the biotech sector. Based in Vancouver, Nik has contributed to cross-functional efforts that advance partnerships with biotechnology and pharmaceutical companies, supporting the translation of antibody discovery technologies into therapeutic programs.
Seminars
Thursday 10th September 2026
Finding a Gap: Achieving Good Response Rates in Difficult Tumor Types
3:00 pm
- How do established payloads compare in their ability to drive meaningful clinical responses?
- Have historically pursued targets lacked sufficient expression or accessibility to enable effective tumor penetration?
- What role can mechanisms play in increasing efficacy?
